PHARMADVICE ApS: Financial statements 2015
CVR: 26527651
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
PHARMADVICE ApS (CVR 26527651) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 4,482,728 and a net result of DKK 195,572 compared with DKK -31,852 the year before. That is an increase of 11.2% compared with the year before. Equity in the 2015 report amounted to DKK 1,145,308. The solvency ratio was 52.2%.
- Gross Profit
- DKK 4,482,728
- Profit/Loss
- DKK 195,572
- Equity
- DKK 1,145,308
- Total Assets
- DKK 2,193,733
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 4.5 mio. | 196 t. | 1.1 mio. | - |
| 2014 | - | 4 mio. | -32 t. | 1 mio. | - |
| 2013 | - | 5.4 mio. | 94 t. | 1.2 mio. | - |
| 2012 | - | 3.4 mio. | -1 t. | 1.2 mio. | - |
Official annual report
How creditworthy is PHARMADVICE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
PHARMADVICE ApS has published its annual report for 2014. Gross profit came to DKK 4,032,729, and the net result was DKK -31,852.
About PHARMADVICE ApS
PHARMADVICE ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2002. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Susanne Ølsgaard Felumb. The company is owned by Felumb Holding ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 6,375,693 and a net result of DKK 503,512 compared with DKK 658,935 the year before. Equity in the 2025 report amounted to DKK 1,402,268.